Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Final Examination Stress and Bowel Symptoms

17 de septiembre de 2026 actualizado por: Demet Öztürk, Lokman Hekim University

The Effect of Final Examination Stress on Bowel Symptoms in University Students

This prospective observational study aims to investigate the association between final examination stress and bowel symptoms in university students. Participants will be evaluated during the final examination period, which represents a naturally occurring period of increased academic stress. Bowel-related symptoms, including constipation-related complaints, defecation-related pain, stool characteristics, and urgency, will be assessed. Participants will also complete a 7-day diary to record bowel characteristics and selected lifestyle factors, including sleep duration, daily step count, and fluid intake. These factors will be examined as potential variables associated with bowel symptoms during the examination period.

Descripción general del estudio

Descripción detallada

University students may experience increased psychological stress during final examination periods due to academic workload, performance expectations, and time pressure. Stress may influence gastrointestinal function through alterations in the brain-gut axis, autonomic nervous system activity, gastrointestinal motility, and visceral sensitivity. Examination periods may also be accompanied by changes in daily lifestyle behaviors, such as sleep duration, physical activity, and fluid intake, which may further influence bowel function.

This prospective, observational, analytical study is designed to evaluate bowel symptoms among university students during the final examination period. Participants will complete a sociodemographic and clinical information form and will be assessed for constipation-related symptoms using Rome IV-based questions. Additional bowel-related characteristics, including pain during defecation, pain intensity and location, urgency to defecate, and stool type, will be recorded.

Participants will also complete a 7-day follow-up diary during the final examination period. The diary will include daily records of defecation-related symptoms and stool characteristics as well as daily fluid intake, step count, and sleep duration. Daily step count and sleep duration will be considered potential lifestyle-related factors associated with bowel symptoms rather than primary outcomes.

The primary objective of the study is to investigate bowel symptoms during a period of final examination stress in university students. Secondary objectives are to examine the relationships between bowel symptoms and selected lifestyle-related factors, particularly sleep duration, physical activity, and fluid intake. No therapeutic, pharmacological, exercise-based, or invasive intervention will be administered as part of the study.

Tipo de estudio

De observación

Inscripción (Estimado)

100

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

The study population will consist of undergraduate university students aged 18 years or older who are enrolled in courses with final examinations during the study period. Eligible students who meet the predefined inclusion and exclusion criteria and voluntarily agree to participate will be included in the study.

Participants will be evaluated during the final examination period, which represents a naturally occurring period of academic stress. During this period, bowel-related symptoms and selected lifestyle factors, including sleep duration, daily step count, and water intake, will be assessed. Participants will also complete a 7-day follow-up diary to record daily bowel characteristics and related symptoms.

Descripción

Inclusion Criteria:

  • Being 18 years of age or older
  • Being an undergraduate university student
  • Being enrolled in courses with final examinations during the study period
  • Being able to complete the study assessments and the 7-day follow-up diary during the final examination period
  • Being able to read and understand Turkish
  • Voluntarily agreeing to participate in the study and providing informed consent

Exclusion Criteria:

  • Having a diagnosed organic gastrointestinal disease that may substantially affect bowel function, such as inflammatory bowel disease, celiac disease, or gastrointestinal malignancy
  • Having a history of major gastrointestinal or pelvic surgery that may affect bowel function
  • Regular use of medications that directly affect bowel motility, such as laxatives or antidiarrheal medications
  • Having an acute gastrointestinal infection, including acute diarrhea or vomiting, during the assessment period
  • Failing to adequately complete the study assessments or the 7-day follow-up diary

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: OTHER
  • Perspectivas temporales: PROSPECTIVE

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
University Students During the Final Examination Period

University students who meet the eligibility criteria and participate in the study during the final examination period will constitute a single observational cohort. Participants will undergo assessment of bowel symptoms and related lifestyle factors during the study period. No allocation or randomization will be performed.

Participants will complete assessments of bowel symptoms and a 7-day diary during the final examination period. The diary will include daily records of bowel-related symptoms, stool characteristics, fluid intake, step count, and sleep duration. No treatment, medication, exercise program, or other therapeutic intervention will be administered.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Constipation-Related Bowel Symptoms
Periodo de tiempo: Baseline

Constipation-related bowel symptoms will be assessed using Rome IV-based questions. The assessment (Rome IV criterias) will include defecation frequency, painful or difficult defecation, large-diameter stools, stool withholding behaviors, sensation of a large fecal mass in the rectum, fecal incontinence, and duration of symptoms.

Baseline

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Defecation-Related Pain
Periodo de tiempo: Daily for 7 consecutive days during the final examination period

Participants will record the presence or absence of pain during defecation each day. When pain is present, its location (abdominal or anal region) and intensity will also be recorded. Pain intensity will be rated on a numerical scale ranging from 0 to 10, with higher scores indicating greater pain intensity.

Daily for 7 consecutive days during the final examination period
Defecation Urgency
Periodo de tiempo: Daily for 7 consecutive days during the final examination period

Participants will record the severity of urgency to defecate each day as mild, moderate, or severe.

Daily for 7 consecutive days during the final examination period
Stool Type
Periodo de tiempo: Daily for 7 consecutive days during the final examination period

Participants will record their daily stool type according to the stool form chart provided in the study diary.

Daily for 7 consecutive days during the final examination period
Daily Step Count
Periodo de tiempo: Daily for 7 consecutive days during the final examination period

Daily step count will be recorded using data obtained from participants' personal smartphones, smartwatches, or other step-counting devices. The mean daily step count across the 7-day monitoring period will also be calculated and evaluated as a lifestyle-related factor potentially associated with bowel symptoms.

Daily for 7 consecutive days during the final examination period
Sleep Duration
Periodo de tiempo: Daily for 7 consecutive days during the final examination period

Participants will record the total duration of sleep for each day in hours. The mean daily sleep duration across the 7-day monitoring period will be calculated and evaluated as a potential factor associated with bowel symptoms.

Daily for 7 consecutive days during the final examination period
Daily Water Intake
Periodo de tiempo: Daily for 7 consecutive days during the final examination period

Participants will record their total daily water intake in milliliters. The mean daily water intake across the 7-day monitoring period will be calculated and examined in relation to bowel symptoms.

Daily for 7 consecutive days during the final examination period

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

1 de diciembre de 2026

Finalización del estudio (Estimado)

30 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

17 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

17 de septiembre de 2026

Publicado por primera vez (Actual)

24 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

24 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

17 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir